- Biotechnology
- Healthcare
Moderna, Inc.
MRNA · US ·
NASDAQ
82.9
USD
+1.61
(1.94%)
-
-15.28
EPS
-
-5.43
P/E
-
31.9B
MARKET CAP
-
0.00%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | -10.5 | -7.18 | -0.99 | 12.9 | 0.385 | 8.48 | 22.90% |
| Avg. Estimate | -15.4 | -8.77 | -6.88 | -3.6 | 0.266 | 5.85 | 18.95% |
| Low Estimate | -22.3 | -9.65 | -9.5 | -8.65 | 0.183 | 4.02 | 16.87% |
| No. Of Analysts | 16 | 15 | 16 | 14 | 6 | 7 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 5.34B | 4.08B | 6.58B | 7.75B | 10.8B | 15.7B | 24.04% |
| Avg. Estimate | 5.05B | 3.44B | 4.04B | 5.76B | 7.99B | 11.7B | 18.22% |
| Low Estimate | 4.82B | 3.01B | 2.62B | 4.37B | 6.07B | 8.85B | 12.93% |
| No. Of Analysts | 18 | 14 | 17 | 18 | 9 | 8 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | -4.69B | -2.74B | -378M | 4.94B | 147M | 3.24B | 21.89% |
| Avg. Estimate | -5.87B | -3.35B | -2.67B | -1.28B | 102M | 2.24B | 18.95% |
| Low Estimate | -7.04B | -3.69B | -3.63B | -3.3B | 69.8M | 1.54B | 17.27% |
| No. Of Analysts | 18 | 14 | 17 | 18 | 9 | 8 |